JSPR Jasper Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: JSPR

Price (delayed)

$0.4665

Market cap

$13.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.68

Enterprise value

-$743,484

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 7
Highlights
JSPR's debt has shrunk by 71% YoY and by 39% QoQ
The EPS is up by 49% year-on-year and by 32% since the previous quarter
JSPR's equity has dropped by 92% year-on-year and by 18% since the previous quarter
JSPR's quick ratio has dropped by 59% year-on-year and by 27% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OPK ORGO

Key stats

What are the main financial stats of JSPR

JSPR stock price

How has the Jasper Therapeutics stock price performed over time
Intraday
-12.36%
1 week
-47.61%
1 month
-52.68%
1 year
-92.23%
YTD
-74.51%
QTD
-46.76%

Financial performance

How have Jasper Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$73.03M
Net income
-$55.73M
Gross margin
N/A
Net margin
N/A
Jasper Therapeutics's net income has increased by 29% YoY and by 26% QoQ
The operating income has increased by 13% since the previous quarter and by 12% year-on-year

Price vs fundamentals

How does JSPR's price correlate with its fundamentals

Growth

What is Jasper Therapeutics's growth rate over time

Valuation

What is Jasper Therapeutics stock price valuation
P/E
N/A
P/B
3.84
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 49% year-on-year and by 32% since the previous quarter
JSPR's equity has dropped by 92% year-on-year and by 18% since the previous quarter
The price to book (P/B) is 34% lower than the last 4 quarters average of 6.6 but 33% higher than the 5-year quarterly average of 3.3

Efficiency

How efficient is Jasper Therapeutics business performance
The company's return on assets has shrunk by 54% YoY but it rose by 10% QoQ
The company's return on equity fell by 41% QoQ

Dividends

What is JSPR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for JSPR.

Financial health

How did Jasper Therapeutics financials performed over time
JSPR's total assets is 19% greater than its total liabilities
JSPR's total assets has dropped by 63% year-on-year and by 41% since the previous quarter
JSPR's quick ratio has dropped by 59% year-on-year and by 27% since the previous quarter
JSPR's debt is 78% lower than its equity
JSPR's equity has dropped by 92% year-on-year and by 18% since the previous quarter
JSPR's debt has shrunk by 71% YoY and by 39% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.